BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21225535)

  • 1. [Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].
    Schlitt HJ; Loss M; Scherer MN; Becker T; Jauch KW; Nashan B; Schmidt H; Settmacher U; Rogiers X; Neuhaus P; Strassburg C
    Z Gastroenterol; 2011 Jan; 49(1):30-8. PubMed ID: 21225535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M
    Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Organ transplantation in Germany: Critical examination in times of scarce resources].
    Haverich A; Haller H
    Internist (Berl); 2016 Jan; 57(1):7-8, 10-4. PubMed ID: 26678283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allocation of liver grafts worldwide - Is there a best system?
    Tschuor C; Ferrarese A; Kuemmerli C; Dutkowski P; Burra P; Clavien PA;
    J Hepatol; 2019 Oct; 71(4):707-718. PubMed ID: 31199941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation in the high MELD era: a fair chance for everyone?
    Bahra M; Neuhaus P
    Langenbecks Arch Surg; 2011 Apr; 396(4):461-5. PubMed ID: 21384189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M; Cillo U; Fagiuoli S; Gasbarrini A; Gavrila C; Marianelli T; Costa AN; Nardi A; Strazzabosco M; Burra P; Agnes S; Baccarani U; Calise F; Colledan M; Cuomo O; De Carlis L; Donataccio M; Ettorre GM; Gerunda GE; Gridelli B; Lupo L; Mazzaferro V; Pinna A; Risaliti A; Salizzoni M; Tisone G; Valente U; Rossi G; Rossi M; Zamboni F;
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
    Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
    Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of MELD-Based Liver Allocation on Patient Survival and Waiting List Mortality in a Country with a Low Donation Rate.
    Ritschl PV; Wiering L; Dziodzio T; Jara M; Kruppa J; Schoeneberg U; Raschzok N; Butz F; Globke B; Seika P; Maurer M; Biebl M; Schöning W; Schmelzle M; Sauer IM; Tacke F; Öllinger R; Pratschke J
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal grafts increase early mortality in liver transplantation.
    Bacchella T; Galvão FH; Jesus de Almeida JL; Figueira ER; de Moraes A; César Machado MC
    Sao Paulo Med J; 2008 May; 126(3):161-5. PubMed ID: 18711655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation in Germany.
    Tacke F; Kroy DC; Barreiros AP; Neumann UP
    Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Liver Transplant Program at the Charité Berlin.
    Pascher A; Neuhaus P
    Clin Transpl; 2010; ():187-94. PubMed ID: 21696041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Actors in liver transplantation advocate greater transparency and systematic evaluations of transplant centres].
    Roeb E; Graf J; Meyer HJ
    Z Gastroenterol; 2014 Aug; 52(8):807-12. PubMed ID: 25111720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match.
    Avolio AW; Agnes S; Gasbarrini A; Nure E; Siciliano M; Castagneto M
    Transplant Proc; 2006 May; 38(4):1059-62. PubMed ID: 16757263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new liver allocation score for transplantation is validated and improved transplant survival benefit in Germany but not in the United Kingdom.
    Schrem H; Focken M; Gunson B; Reichert B; Mirza D; Kreipe HH; Neil D; Kaltenborn A; Goldis A; Krauth C; Roberts K; Becker T; Klempnauer J; Neuberger J
    Liver Transpl; 2016 Jun; 22(6):743-56. PubMed ID: 26947766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waiting time, not donor-risk-index, is a major determinant for beneficial outcome after liver transplantation in high-MELD patients.
    Rauchfuss F; Zidan A; Scheuerlein H; Dittmar Y; Bauschke A; Settmacher U
    Ann Transplant; 2013 May; 18():243-7. PubMed ID: 23792527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.